Thursday, December 28, 2023 3:47:36 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ALXO News
- ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium • GlobeNewswire Inc. • 12/18/2024 01:00:00 PM
- ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024 • GlobeNewswire Inc. • 12/12/2024 01:00:00 PM
- ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer • GlobeNewswire Inc. • 12/10/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2024 09:15:29 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 12/02/2024 09:06:36 PM
- ALX Oncology to Participate in the Piper Sandler 36th Annual Healthcare Conference • GlobeNewswire Inc. • 11/26/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2024 09:05:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 01:03:07 PM
- ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer • GlobeNewswire Inc. • 11/14/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:03:10 PM
- ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/07/2024 09:00:00 PM
- ALX Oncology Announces November Investor Conference Participation • GlobeNewswire Inc. • 11/04/2024 01:00:00 PM
- ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024 • GlobeNewswire Inc. • 11/01/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 01:00:07 PM
- ALX Oncology to Present at the 2024 Cantor Fitzgerald Global Healthcare Conference • GlobeNewswire Inc. • 09/09/2024 12:00:00 PM
- ALX Oncology Announces First Patients Dosed with Evorpacept and Sarclisa As Part of Randomized Phase 1/2 UMBRELLA Study with Sanofi • GlobeNewswire Inc. • 09/04/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 09:10:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 09:09:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 09:06:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:03:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:08:01 PM
- ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 09:23:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 09:22:35 PM
FEATURED Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM